Follow this blog:
RSS

The Morning Briefing: Patents and rulings

By | July 18, 2012, 1:23 AM PDT

“The Morning Briefing” is SmartPlanet’s daily roundup of must-reads from the web. This morning we’re reading about court rulings in patent disputes.

1.) Teva Pharma says U.K. court supports MS drug patent. A U.K. court has ruled in favor of Teva Pharmaceutical in regard to dispute over a patent supporting its multiple sclerosis drug.

2.) Schering-Plough’s K-Dur pay-for-delay ruling reversed. Merck & Co.’s Schering-Plough unit must face a challenge to its agreement with competitors to keep generic versions of its drug K-Dur off the market, an appeals court ruled, reversing a lower-court antitrust decision.

3.) RIM forced to pay $147 million damages over patent dispute. RIM has been found liable of infringing software patents held by Mformation Technologies. There goes $147 million in damages for the BlackBerry manufacturer — more cash it can’t afford to lose.

4.) Yahoo and Facebook settle patent dispute, forge advertising alliance. Facebook and Yahoo have agreed to settle a months-long patent dispute, averting a potentially expensive battle over the technology running two of the Internet’s most popular destinations.

5.) Secrecy bid in Apple vs. Samsung lawsuit denied. Requests to cloak the patent dispute in secrecy made by both Apple Inc and Samsung Electronics Co. have been been denied by a U.S. judge.

Image credit: Johan Larsson

Start your week smarter with our weekly e-mail newsletter. It's your cheat sheet for good ideas. Get it.

Charlie Osborne

About Charlie Osborne

Charlie Osborne is a contributing editor for SmartPlanet.

Charlie Osborne

Charlie Osborne

Contributing Editor

Charlie Osborne is a freelance journalist and graphic designer based in London. In addition to SmartPlanet, she also writes the iGeneration column for business technology website ZDNet. She holds degrees in medical anthropology from the University of Kent.

Follow her on Twitter.

Charlie Osborne

Charlie Osborne

Charlie Osborne does not have financial holdings that would influence how or what she covers.

She writes for SmartPlanet and is not an employee of CBS.

If you liked this, don't miss...
1
Comments

Join the conversation!

Follow via:
RSS
0 Votes
+ -
Costly Patenting
Patenting a new product is a very costly exercise and patent protection is only as good as the money you have to defend a patent infringement.
In Australia patent attorneys are notorious for stealing their clients' fees with impunity and a particularly telling story can be savored on this website:
http://www.ipta-info.com
Posted by kwickset@...
18th Jul
Join the conversation
Formatting +
BB Codes - Note: HTML is not supported in forums
  • [b] Bold [/b]
  • [i] Italic [/i]
  • [u] Underline [/u]
  • [s] Strikethrough [/s]
  • [q] "Quote" [/q]
  • [ol][*] 1. Ordered List [/ol]
  • [ul][*] · Unordered List [/ul]
  • [pre] Preformat [/pre]
  • [quote] "Blockquote" [/quote]

Join the SmartPlanet community and join the conversation! Signing up is fast and free. Don't wait -- we want to hear your opinion!